IP Library Patent Application 12231030
Patent Application
App. No. 12/231,030

Electrogenic pump molecule control

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/231,030
Abstract

Activation of electrogenic pump molecules can be realized by a dynamic entrainment procedure which includes two steps: synchronization of individual pump molecules to work at the same pumping pace, and gradual modulation of the synchronization frequency. We studied synchronization of the Na/K pump molecules in a physiological running mode by applying the concept of an electronic synchrotron to the biological system. Both theoretical analysis and experimental results showed that individual Na/K pump molecules can be synchronized by a well designed oscillating electric field. The synchronized pump currents show separated inward and outward pump currents and a magnitude ratio of 3:2 reflecting stoichiometric number of the pump molecules.

Claims (8)

1 . A method of controlling the function of a set of pump molecules comprising the steps of synchronizing the pump molecule by applying an oscillating electric field wherein the oscillating electric field synchronizes the moleclues' pumping paces and modulating the pump molecules by adjusting the synchronization frequency wherein the adjusting entrains the pump molecules to pump at a defined rate.

2 . The method according to claim 1 wherein the applied oscillating electric field is applied at a frequency comparable to the pumps' natural turnover rate to synchronize the molecules' pumping rate.

3 . The method according to claim 1 wherein the pump molecule is a Na/K pump molecule.

4 . A method of treating a disease in a subject characterized by a deregulation in a pump molecule function comprising the step of electrogenically treating one or more pump molecules in the subject in need of such treatment by synchronization and modulation of the molecule.

5 . The method according to claim 4 wherein the electrogenically treating one or more pump molecules in the subject in need of such treatment by synchronization and modulation of the molecule comprises the steps of synchronizing the pump molecule by applying an oscillating electric field wherein the oscillating electric field synchronizes the moleclues' pumping paces and modulating the pump molecules by adjusting the synchronization frequency wherein the adjusting entrains the pump molecules to pump at a defined rate.

6 . The method according to claim 5 wherein the applied oscillating electric field is applied at a frequency comparable to the pumps' natural turnover rate to synchronize the molecules' pumping rate.

7 . The method according to claim 4 wherein the pump molecule is a Na/K pump molecule.

8 . The method according to claim 4 wherein the disease is selected from the group consisting of myotonic dystrophy, diabetes, cystic fibrosis, central nervous system disorder, McArdle disease, various aging diseases, such as Alzheimer's diseases, Huntington's diseases.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 28, 2009
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023012/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2008
From: CHEN, WEI
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 021576/0449 →